Trade EYPT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
EyePoint, Inc. (EYPT) is trading at US$4.23, down 0.47% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$458.65M. Over the past 52 weeks, EYPT has traded between US$3.95 and US$19.11. On Syfe you can trade EYPT with $0 commission and add it to your watchlist.
| Previous close | US$4.25 |
|---|---|
| Market cap | US$458.65M |
| 52-week range | US$3.95 – US$19.11 |
| Volume | 2.72M |
| Exchange | US |
Add to Watchlist
Set Price Alert
EyePoint, Inc.
EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Year: 2005
EyePoint, Inc. (EYPT) stock is trading at US$4.23, -0.47% from the previous close of US$4.25.
The market cap for EyePoint, Inc. (EYPT) stock is approximately US$458.65M.
The 52-week high for EyePoint, Inc. (EYPT) stock is US$19.11.
The 52-week low for EyePoint, Inc. (EYPT) stock is US$3.95.
EyePoint, Inc. (EYPT) does not currently pay a dividend.
Stay on top of EYPT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
